The Latest Cardiac and Vascular News
WEST CHESTER, Pa., June 15, 2023 /PRNewswire/ — VESTECK (WWW.VESTECK.com) is a clinical stage medical device company focused on bringing a proprietary technology to the aortic repair and structural heart markets. The “SUTURE-TIGHT™” catheter comes preloaded with 4 pair of nitinol sutures, it secures endovascular (EVAR/TEVAR) grafts to the aorta on initial implant […]
Addition to Pounce™ thrombectomy platform with the low-profile (LP) model will allow for efficient clot removal in below-the-knee peripheral arteries (2 mm to 4 mm), expanding the addressable market for the Pounce™ platform EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic […]
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Reflow Medical, Inc. announced the six-month results of the DEEPER OUS clinical trial (NCT03807531) evaluating the safety and efficacy of the Bare Temporary Spur Stent System. Results were presented at the annual Leipzig International Course (LINC) in Leipzig, Germany. Michael Lichtenberg, MD, FESC, Chief Medical Officer and […]
The Gore VBX FORWARD Clinical Study aims to compare the VBX Stent Graft primary patency to bare metal stenting to evaluate superiority in treating complex iliac occlusive disease. FLAGSTAFF, Ariz., June 13, 2023 /PRNewswire/ — W. L. Gore & Associates (Gore) announced today the initiation of the Gore VBX FORWARD Clinical Study (NCT05811364) […]
MIAMI–(BUSINESS WIRE)–Ambulero, Inc. is developing a first-in-class gene and cell therapy platform for treating serious vascular diseases and non-healing wounds where amputation is a care option. In support of this effort, the NHLBI CATALYZE program of the National Institutes of Health approved a second phase of funding for IND-enabling work […]
IRVINE, Calif.–(BUSINESS WIRE)–Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, announced today that the U.S. Food and Drug Administration (FDA) has granted approval for the DETOUR System to treat patients with complex peripheral arterial disease (PAD). Over […]
IRVINE, Calif., June 07, 2023 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced the launch of two new purpose-built products, the RevCore thrombectomy catheter, and the Triever16 […]
IRVINE, Calif, June 7, 2023 /PRNewswire/ — Innova Vascular, Inc. announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Laguna Clot Retriever™ System and its Malibu Aspiration Catheter™ System for use in the peripheral vasculature. The two new devices are collectively known as the Laguna Thrombectomy System. […]
CAUTION: Investigational device. Limited by United States law to investigational use. FIRST U.S. PATIENT ENROLLED IN GORE® VIAFORT Vascular Stent ILIOFEMORAL pivotal study FLAGSTAFF, Ariz., June 6, 2023 /PRNewswire/ — W. L. Gore & Associates (Gore) has announced that the first U.S. patient has been enrolled in a prospective, non-randomized, multicenter, single-arm study with five-year follow-up […]
First and Only IO Needle with MR Conditional Safety Status Labeling WAYNE, Pa., June 06, 2023 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, today announced that the Arrow® EZ-IO® Needle is the first and only Intraosseous (IO) Needle to receive […]
